Inventor · disambiguated record
Vered Rosenberger
Also filed as: ROSENBERGER VERED
13 granted patents·33 pending applications·704 citations·filing 1997–2023
93Inventor score
Top patents by PatentIndex Score
46 records- 0197US6197331B1Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavityPERIO PROD LTD·Filed 1997·Granted Mar 6, 2001·317 cites·19 claims
- 0296US7195778B2Drug delivery system for zero order, zero order-biphasic, ascending or descending drug deliveryTEVA PHARMA·Filed 2002·Granted Mar 27, 2007·177 cites·44 claims
- 0394US8663703B2Drug microparticles, processes of preparing them and a drug delivery vehicle comprising themLERNER E ITZHAK·Filed 2009·Granted Mar 4, 2014·62 cites·8 claims
- 0494US6881420B2Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferationTEVA PHARMA·Filed 2001·Granted Apr 19, 2005·58 cites·25 claims
- 0592US10548837B1Topical montelukast for treatment of atopic dermatitisTARO PHARMA IND·Filed 2017·Granted Feb 4, 2020·7 cites·7 claims
- 0689US6476006B2Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonatesTEVA PHARMA·Filed 2001·Granted Nov 5, 2002·54 cites·42 claims
- 0785US7611722B2Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing itTEVA PHARMA·Filed 2003·Granted Nov 3, 2009·18 cites·32 claims
- 0879US9107832B2Risperidone microparticles formed by sublimationTEVA PHARMA·Filed 2014·Granted Aug 18, 2015·1 cites·8 claims
- 0977US7674480B2Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the compositionTEVA PHARMA·Filed 2001·Granted Mar 9, 2010·10 cites·24 claims
- 1075US2023248641A1Topical montelukast for treatment of atopic dermatitisTARO PHARMA IND·Filed 2023·Application pending·0 cites
- 1170US11844861B2Topical Montelukast formulationsTARO PHARMA IND·Filed 2021·Granted Dec 19, 2023·0 cites·23 claims
- 1265US11173117B2Topical Montelukast formulationsTARO PHARMA IND·Filed 2021·Granted Nov 16, 2021·0 cites·27 claims
- 1363US2006141051A1Drug microparticlesLERNER E I·Filed 2006·Application pending·0 cites
- 1463US2006141052A1Drug microparticlesLERNER E I·Filed 2006·Application pending·0 cites
- 1563US2009263482A1Treatment of inflammatory bowel disease with 6-mercaptopurineROSENBERGER VERED·Filed 2009·Application pending·0 cites
- 1663US2023059107A1Stable topical compositions of fenoldopamTARO PHARMA IND·Filed 2022·Application pending·0 cites
- 1762US2006233879A1Controlled released dosage formsTEVA PHARMA·Filed 2006·Application pending·0 cites
- 1862US2006233880A1Controlled release dosage formsTEVA PHARMA·Filed 2006·Application pending·0 cites
- 1961US2005048086A1Compositions and dosage forms for gasteric delivery of antineoplastic agents and methods of treatment that use them to inhibit cancer cell proliferationFiled 2004·Application pending·0 cites
- 2061US2010278912A1Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the compositionTEVA PHARMACEUTICALS USA INC F·Filed 2007·Application pending·0 cites
- 2161US2020237651A1Topical montelukast for treatment of atopic dermatitisTARO PHARMA IND·Filed 2020·Application pending·0 cites
- 2259US2006141050A1Drug microparticlesLERNER ITZHAK E·Filed 2006·Application pending·0 cites
- 2358US11446237B2Stable topical compositions of fenoldopamTARO PHARMA IND·Filed 2020·Granted Sep 20, 2022·0 cites·20 claims
- 2458US2014370105A1Treatment of inflammatory bowel disease with 6-mercaptopurineTEVA PHARMA·Filed 2014·Application pending·0 cites
- 2558US2003224059A1Drug microparticlesFiled 2003·Application pending·0 cites
- 2657US2005112202A1Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing itFiled 2004·Application pending·0 cites
- 2756US12233055B2Topical Montelukast formulationsTARO PHARMA IND·Filed 2021·Granted Feb 25, 2025·0 cites·11 claims
- 2856US2010151020A1Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidateROSENBERGER VERED·Filed 2009·Application pending·0 cites
- 2955US2007178149A1Levodopa compositionsFLASHNER-BARAK MOSHE·Filed 2006·Application pending·0 cites
- 3055US2013280328A1Treatment of inflammatory bowel disease with 6-mercaptopurineROSENBERGER VERED·Filed 2013·Application pending·0 cites
- 3153US2004122065A1Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or buccallyFiled 2003·Application pending·0 cites
- 3253US2005026871A1Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivativeFiled 2003·Application pending·0 cites
- 3351US2004198646A1Menthol solutions of drugsFiled 2004·Application pending·0 cites
- 3451US2001024657A1Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavityFiled 2001·Application pending·0 cites
- 3549US2006141028A1Cyclosporin formulationsFLASHNER-BARAK MOSHE·Filed 2005·Application pending·0 cites
- 3649US2007148233A1Pharmaceutical formulations of fenofibrate having improved bioavailabilityLERNER E I·Filed 2005·Application pending·0 cites
- 3749US2006222707A1Formulations of fenofibrateLERNER E I·Filed 2006·Application pending·0 cites
- 3849US2007015834A1Formulations of fenofibrate containing PEG/PoloxamerFLASHNER-BARAK MOSHE·Filed 2005·Application pending·0 cites
- 3949US2007015833A1Formulations of fenofibrate containing mentholFLASHNER-BARAK MOSHE·Filed 2005·Application pending·0 cites
- 4047US2005170004A1Nanoparticles for drug deliveryFiled 2004·Application pending·0 cites
- 4147US2006153918A1Dosage forms with an enterically coated core tabletLERNER E I·Filed 2005·Application pending·0 cites
- 4247US2005113452A1Composition and dosage form for sustained effect of levodopaFiled 2004·Application pending·0 cites
- 4345US2005192340A1Simvastatin formulations and methods of making sameFiled 2004·Application pending·0 cites
- 4444US2003203878A1Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonatesFiled 2003·Application pending·0 cites
- 4540US2004052843A1Controlled release dosage formsFiled 2003·Application pending·0 cites
- 4638US2006018957A1Pharmaceutical dosage forms including rasagilineLERNER E I·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vered Rosenberger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →